What happens when psychedelic therapy gets approved? Kimberly Chew explains FDA rules, costs, insurance, safety and access.

Discover how AI is transforming psychedelic integration by helping practitioners provide personalized support between sessions without replacing care.

John Gilchrist of Therapsil explains how psilocybin therapy is helping end-of-life patients ease anxiety, find meaning, and embrace acceptance.

Christian Rasmussen explains what people get wrong about Amanita muscaria, its reported effects, and key safety considerations.

Considering psychedelic work? Learn key safety guidelines, red flags to watch for, and how preparation and integration support lasting change.

Explore iboga and ibogaine through their African roots, safety protocols, addiction research, and the deeply introspective experiences they can inspire.

Podcast guest Jonathan Mozenter explains why psychedelic breakthroughs alone rarely create lasting change—and how preparation, integration, and updating old mental patterns lead to real transformation.

A deeply personal conversation with Stuart Preston on grief, loss, and healing—exploring how meditation, therapy, and intentional psychedelic use can open space for meaning, acceptance, and emotional release.